Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin tablets for bacterial vaginitis and threatened preterm birth in pregnant women
jRCTs021190020Completed
- Sponsor
- Akita University Hospital
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of lactoferrin in bacterial vaginosis (BV), cervicitis and preterm birth (2 arms), sponsored by Akita University Hospital. Primary endpoints: Improvement in vaginal discharge findings and Preterm birth rate. Started Feb 2020; status: completed.
02
Drugs
lactoferrin
03
Conditions
bacterial vaginosis (BV)cervicitispreterm birth
Beyond the preview
Go deeper on jRCTs021190020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190020.